Next-Generation Oncolytic Viruses to Overcome Resistance to Anti-PD-1 Therapy in Melanoma. [PDF]
J Clin OncolMcArthur GA.
europepmc +1 more source
Advancements on the synergistic application of oncolytic viruses and molecularly targeted therapies for the treatment of solid tumors (Review). [PDF]
Int J OncolBi S, Shan T, Tang Y, Wang Q.
europepmc +1 more source
Going viral: targeting glioblastoma using oncolytic viruses. [PDF]
Immunother AdvCoates K, Nibbs RJ, Fraser AR.
europepmc +1 more source
Hydrogel Micro/Nanostructures for the Delivery of Oncolytic Viruses: Overcoming Limitations and Improving Efficacy. [PDF]
Adv Pharm BullHsu CY +9 more
europepmc +1 more source
Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential. [PDF]
Front MicrobiolGupta A +3 more
europepmc +1 more source
A new strategy for melanoma treatment: an investigation of the clinical value of the combination of immune checkpoint inhibitors and oncolytic viruses. [PDF]
Cancer Cell IntSui B, Jin X, Zheng X.
europepmc +1 more source
Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734. [PDF]
VirusesNitschke FD +6 more
europepmc +1 more source
Harnessing oncolytic viruses to overcome immunosuppression in breast cancer: from mechanisms to clinical translation. [PDF]
Front ImmunolXianshu K +6 more
europepmc +1 more source
Combination therapy with oncolytic viruses for lung cancer treatment. [PDF]
Front OncolSun L, Zhao Q, Miao L.
europepmc +1 more source
Deciphering permissivity of human tumor ecosystems to oncolytic viruses. [PDF]
OncogeneSchoeps B, Lauer UM, Elbers K.
europepmc +1 more source